DBE tables for FDA submission [Regulatives / Guidelines]

posted by avinash – India, 2014-01-27 12:59 (4532 d 21:51 ago) – Posting: # 12274
Views: 8,028

Dear Members,

My question with regard to DBE tables for FDA submission studies.

Under Table 9 “Reanalysis of Study Samples”

Two sections are there
1) Number of samples reanalyzed
2) Number of recalculated values used after reanalysis

Can any one please explain me what is the difference between these two sections?

Thanks & regards,
Avinash Jain

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
316 visitors (0 registered, 316 guests [including 20 identified bots]).
Forum time: 11:51 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5